Our Guest: Chris Bahl, Co-Founder, President & Chief Scientific Officer at AI Proteins
What you'll get out of this episode:
- Bahl's background
- Overview of AI Proteins
- How they are utilizing computational protein design to engineer synthetic miniproteins therapeutics that can bind to any target
- The process and challenges
- Key differentiators
- Their impact on the future of medicine
Our sponsors for this episode are Sage Growth Partners
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartners
What is BioBreakthroughs?
Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.